BUZZ-Australia's <a href="https://laohu8.com/S/ATX.AU">Amplia Therapeutics</a> falls as HY loss widens** Shares of Amplia Therapeutics ATX.AX fall 3.6% to A$0.135, on track for their weakest session since November 18** The clinical-stage, drug development co's HY loss attributable widens to A$4.2 million ($2.75 million) from A$2.8 million last year** However, ATX up 21.7% this week, set for its strongest week since July 10** Stock up 51.7% YTD
($1 = 1.5300 Australian dollars)
(Reporting by Jasmeen Ara Shaikh in Bengaluru)
((Jasmeenaraislam.shaikh@thomsonreuters.com ))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments